Gastric Cancer 90 Gene Testing with Audit-Ready Reporting

Overview

Gastric cancer testing must satisfy both clinical guidance and the documentation rules payers require. The ninety-gene gastric panel reports targeted, chemotherapy, and MSI or MMR findings in audit-ready form. Structured output eases compliance review for hospitals and reimbursement submissions. Documented method trails reduce the back-and-forth that delays reimbursement.

How It Works

One captured library covers the ninety genes and the mismatch-repair markers in a single run. Laboratory information systems record every step so the result carries a full trace. MSI is computed from marker stability while MMR genes are called for deleterious change. A certificate of analysis accompanies batches that procurement or auditors request. Every reagent and instrument step is logged so the report is fully reconstructable.

Indications

Centers needing reimbursable immune eligibility evidence use the panel's MSI or MMR lines. Programs under quality accreditation adopt it for the documented method trail. Programs with mixed payer mixes rely on the standardized layout to satisfy each reviewer. Complex cases where payer policy demands standardized reporting are well served. Centers under audit adopt it because the trace satisfies reviewer expectations.

Specimen Requirements & Reporting

Turnaround is about nine business days with results formatted to payer specifications. The document separates somatic findings from the compliance markers reviewers expect. Archived validation data supports later audit requests without re-running samples. MSI and MMR are computed in the same run to avoid duplicate specimen draws.

Storage & Sourcing

Samples and data are kept under regulated retention with access controls and logs. Specimen transport follows biological goods rules with tracked cold packaging. Accredited networks receive consolidated certificates and scheduled quality reports. Scheduled quality reports give networks the evidence their accreditation bodies require. Quarterly summaries roll the evidence into a single accreditation package.

FAQ

Q: What quality standards govern the 90-gene gastric panel? A: The run is recorded end to end by the laboratory system, and certificates of analysis support accreditation and audit needs.

Q: Are MSI and MMR results reportable for reimbursement? A: Yes, microsatellite and mismatch-repair outcomes are reported in the format payers expect for immune eligibility claims.

Q: How is sample identity protected through testing? A: Access-controlled retention, full chain-of-custody logging, and barcode tracking protect sample identity at every step.

Q: Can the laboratory issue a certificate of analysis? A: A certificate of analysis accompanies batches on request for procurement, accreditation, or payer review.